🔗 Share this article

A shadow economy for unapproved weight-loss drugs is being driven by social media fitness personalities and vendors on messaging platforms, according to recent findings.

Investigational Drug Acquiring Traction Via Social Media

Retatrutide, which is still in research studies, is being advertised by social media influencers for its supposed weight-reducing properties. Viewers are encouraged to message these profiles privately for source information, while also obtaining promotional offers.

Thriving Trade on Messaging Platforms

Additionally, a flourishing trade exists on messaging services, where groups with thousands of members share “before and after” images, administration instructions and claims of rapid British shipping. Vendors promote the drug there before directing buyers to WhatsApp for purchases.

Learning About Retatrutide

Retatrutide is an investigational injection created by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could assist individuals reduce up to a quarter of their body weight. Referred to as the “triple G”, the substance is being promoted online as the successor to Ozempic.

Healthcare Experts Voice Worries

However, physicians and chemists have cautions that the distribution of what is still an unlicensed drug in the United Kingdom is a cause for concern and could lead to users administering products of uncertain source.

Several experts stated the demand for retatrutide could be connected to the rising cost of approved slimming products such as Mounjaro.

Legal Status and Enforcement

Marketing retatrutide on social media or messaging apps is prohibited in the United Kingdom, as it is an unlicensed medication that cannot be promoted or supplied for human use under the British medical regulations.

Some influencers try to sidestep the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but advertising and distribution can still violate medicines, marketing, and consumer laws, potentially leading to fines, legal action or imprisonment.

Platform Reaction and Material Removal

According to TikTok, the service has taken down problematic material and prohibited related keywords and search suggestions. The company said it was dedicated to keeping the platform secure and allocating resources in enhancing compliance measures.

Online Trading Operations

Research also discovered groups with up to 9,000 members marketing retatrutide using Telegram's built-in search feature, which functions like a online catalog. Typing “retatrutide” immediately displays channels with thousands of users, filled with images of slimming results, glowing testimonials and detailed instructions for mixing or injecting at residence.

After moments of joining one group, a seller shared WhatsApp details, where most purchases occur. The seller provided an instruction manual and guaranteed delivery within two days. When questioned whether the product was authentic, one seller responded: “You can’t be sure.” Another shared a photo of a supposed testing documentation. Not one asked about weight, health issues or past usage.

Item Details and Costs

Within these groups, messages display dark colored parcels with Royal Mail stickers, stating to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, prepared at residence with sterile water, or ready-to-use pens usually priced at £160 for 20mg. When questioned how much time a pen should be used, vendors give conflicting answers varying between a several days to “depends on your body”.

Platform Moderation and Safety Actions

A spokesperson for the messaging service said it regularly monitored dangerous material on its platform including material that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“Individuals are injecting substances they can’t verify. Although the science behind retatrutide is sound, these online products may not include what they claim,” stated a pharmacy expert, the head of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor linked the surge in demand to recent cost increases for approved slimming drugs such as Mounjaro. “With costs rising, patients are turning to online platforms. But counterfeit treatments are extremely dangerous. You cannot know what’s inside or whether the environment they were made in was sterile,” she said.

Her staff has previously seen patients injured by self-injection from unverified sources. “We recognize the frustration, but purchasing from messaging apps or communication platforms is taking chances with your well-being,” said Wyllie. “These substances could be impure or incorrectly dosed.”

Manufacturer Position

A representative from Eli Lilly said retatrutide was in phase 3 clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Consequently at this time no one can market [it] for personal consumption,” they explained, adding that any item “falsely representing itself as a company experimental substance not yet authorized … may expose users to potentially serious medical dangers”.